Refine by
Antigen Selection Equipment & Supplies
13 equipment items found
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
At TREOS we use knowledgebase and algorithm embedded in PASCal (Personal Antigen Selection Calculator) tool to develop personal cancer immunotherapies. PASCal supports the development of immunotherapies for single individuals and a population of individuals with a specific genetic background, including specific peptides most effective in ethnic ...
Manufactured by:Dia.Pro Diagnostic Bioprobes s.r.l based inSesto San Giovanni, ITALY
The test can be used in addition to identify (a) the specificity (“typing”) of antibodies to the major immunodominant COVID-19 antigens and (b) identify those samples with a titer of “potentially” neutralizing IgG to Spike antigens such to select the donor as a candidate for immunotherapy, as well. ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
LOCAMETZ, after radiolabeling with gallium-68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy, with suspected recurrence based on elevated serum prostate-specific ...
Manufactured by:Adaptive Biotechnologies based inSeattle, WASHINGTON (USA)
Our TCR-antigen discovery capabilities may inform the design and development of next-generation vaccines. Adaptive has validated hundreds of immunogenic antigens that can be selected to design differentiated vaccines. Our platform is also used to detect and track vaccine-induced antigen-specific T cell responses ...
Manufactured by:Akshaya Bio Inc. based inEdmonton, ALBERTA (CANADA)
The Chimigen® Platform is a flexible platform vaccine technology designed to elicit both humoral and cellular immune responses in ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major contributor to acute respiratory infection and pneumonia with rates of pneumonia (Clinics in Chest Medicine 2017) and hospitalization (JID 2012) similar ...
Manufactured by:Institut Virion\Serion GmbH based inWurzburg, GERMANY
SERION ELISA classic tests are qualitative and quantitative immunoassays for the detection of human antibodies directed against specific antigens of bacteria, viruses, fungi and parasites in serum, plasma or, when indicated, cerebrospinal fluid, for the diagnosis of infectious diseases. SERION ELISA antigen tests are qualitative and quantitative immunoassays for the detection of pathogen specific ...
Manufactured by:Qualigen Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
These same technologies are now the basis for the Company’s expansion into therapeutic applications for the treatment of cancer and infectious disease. Qualigen’s Selective Target Antigen Removal System (STARS), is an investigational therapeutic device product currently under development and evaluation that will utilize core expertise in advanced ...
Manufactured by:Biopanda Reagents Ltd based inBelfast, UNITED KINGDOM
The Biopanda TB-ELiFN kit is an enzyme linked immunosorbent assay (ELISA) for the quantitative determination of Interferon gamma (IFN-γ) released by memory T cells in human whole blood through in vitro stimulation with specific Mycobaterium tuberculosis (MTB) antigens. This test is an aid in the diagnosis of human tuberculosis (TB) ...
by:Sumitomo Pharma Oncology, Inc. based inCambridge, MASSACHUSETTS (USA)
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines have failed to drive sufficient tumor immunogenicity, leading to poor clinical responses.1 The reason for this may be that previous vaccine models used inadequate ...
Manufactured by:DSS Takara Bio India Pvt Ltd based inNew Delhi, INDIA
SARS-CoV-2 research is happening at breakneck speed, and scientists are trying to identify epitopes that could trigger an immune response to the virus, an important step in the development of novel vaccines. Takara Bio offers an array of innovative technologies to support this endeavor. The development of a vaccine involves an analysis of the viral and host genomes using sequencing and ...
by:Mazen Animal Health based inAmes, ALABAMA (USA)
This pioneering approach enhances animal welfare, worker safety, and biosecurity by leveraging mucosal immunity to protect against pathogens. The platform's efficacy is driven by a methodical process including protein design, where subunit antigens are selected to target diseases effectively, followed by the insertion of these genes into the corn genome to ...
by:Pure Biologics SA based inWroclaw, POLAND
In cancer, a balance between immune system effector and regulatory cells becomes disturbed. Regulatory T cells inhibit the activity of effector cells, including NK cells, a process known as immunosuppression. The PB003 (PureActivator) project embraces a novel approach, aiming to develop a drug based on a bimodal fusion protein, which synergistically activates NK cells and minimizes ...